PHS
DXC icon

PFM Health Sciences’s DXC Technology DXC Stock Holding History

PFM Health Sciences’s Portfolio DXC Stock Details DXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-539,926
Closed -$44.3M – 96
2017
Q4 		$44.3M Sell
539,926
-1,498
-0.3% -$121K 1.05% 41
2017
Q3 		$40.2M Sell
541,424
-362,428
-40% -$25.7M 0.79% 44
2017
Q2 		$60M Buy
+903,852
New +$60M 1.62% 25

Other funds holding DXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PFM Health Sciences's DXC Position: Q1 2018 in Review

PFM Health Sciences sold out of DXC Technology (DXC) in Q1 2018, closing a stake of 539,926 shares — an estimated $44.3M sold.

PFM Health Sciences first reported a position in DXC in Q2 2017 and held it in 3 quarters. The position peaked at $60M in Q2 2017. 863 funds tracked by Wall St. Rank hold DXC as of Q1 2018.

  • PFM Health Sciences reported no remaining DXC Technology position as of Q1 2018 after selling out during the quarter.
  • PFM Health Sciences sold 539,926 DXC Technology shares in Q1 2018, an estimated $44.3M.
  • PFM Health Sciences first reported a position in DXC Technology in Q2 2017 and held it in 3 quarters.
  • PFM Health Sciences's DXC Technology position peaked at $60M in Q2 2017.
  • 863 funds tracked by Wall St. Rank held DXC Technology as of Q1 2018.

Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.